https://www.indianpharmapost.com/gmm-pfaudler-posts-q3-fy23-consolidated-profit-at-rs-1867-cr-136792023-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/theramex-select-cara-life-sciences-platform-to-consolidate-and-digitise-regulatory-processes-136802023-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/apollo-hospitals-partners-with-medisage-136812023-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/dabur-india-consolidated-q3fy23-pat-lower-at-rs-47594-cr-136822023-02-03T00:00:00+05:30always0.9